Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell LymphomaKhushali Jhaveri, Ram Thapa, Dalia Ercan, et al.
Gastroenterology|December 17, 2020
Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early DetectionJohannes F Fahrmann, C Max Schmidt, Xiangying Mao, et al.
Cell Reports. Medicine|September 20, 2023
A blood-based metabolomic signature predictive of risk for pancreatic cancerEhsan Irajizad, Ana Kenney, Tiffany Tang, et al.
Cell Reports|December 22, 2015
Long Noncoding RNA Ceruloplasmin Promotes Cancer Growth by Altering GlycolysisRajesha Rupaimoole, Jaehyuk Lee, Monika Haemmerle, et al.
Ebiomedicine|December 1, 2023
Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trialXiaotao Zhang, Ehsan Irajizad, Kristi L Hoffman, et al.
Gut|April 23, 2025
Long-chain sulfatide enrichment is an actionable metabolic vulnerability in intraductal papillary mucinous neoplasm (IPMN)-associated pancreatic cancersYihui Chen, Riccardo Ballarò, Marta Sans, et al.
The Journal of Clinical Endocrinology and Metabolism|June 12, 2023
Blood-based Proteomic Signatures Associated With MEN1-related Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Cancer Letters|February 9, 2025
Elevated levels of circulating microbial-associated uremic toxins are associated with metastatic duodenopancreatic neuroendocrine tumors in patients with Multiple Endocrine Neoplasia Type 1Riccardo Ballarò, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Cell Reports. Medicine|November 17, 2022
A polyamine-centric, blood-based metabolite panel predictive of poor response to CAR-T cell therapy in large B cell lymphomaJohannes F Fahrmann, Neeraj Y Saini, Chang Chia-Chi, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2021
A Blood-based Polyamine Signature Associated With MEN1 Duodenopancreatic Neuroendocrine Tumor ProgressionJohannes F Fahrmann, Amanda R Wasylishen, Carolina R C Pieterman, et al.
Pageof 8